Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions.

Elderly Americans, especially those with multiple chronic conditions, face difficulties paying for prescriptions, which results in worse adherence to and discontinuation of therapy, called cost-related medication nonadherence. Medicare Part D, implemented in January 2006, was supposed to address issues of affordability for prescriptions. We investigated whether the gains in medication affordability attributable to Part D persisted during the six years that followed its implementation. Overall, we found continued incremental improvements in medication affordability in the period 2007-09 that eroded during the period 2009-11. Among elderly beneficiaries with four or more chronic conditions, we observed an increase in the prevalence of cost-related nonadherence from 14.4 percent in 2009 to 17.0 percent in 2011, reversing previous downward trends. Similarly, the prevalence among the sickest elderly of forgoing basic needs to purchase medicines decreased from 8.7 percent in 2007 to 6.8 percent in 2009 but rose to 10.2 percent in 2011. Our findings highlight the need for targeted policy efforts to alleviate the persistent burden of drug treatment costs on this vulnerable population.

[1]  Jeanne M. Madden,et al.  Cost-related Medication Nonadherence in Older Patients with Rheumatoid Arthritis , 2013, The Journal of Rheumatology.

[2]  Yuting Zhang,et al.  The vast majority of Medicare Part D beneficiaries still don't choose the cheapest plans that meet their medication needs. , 2012, Health affairs.

[3]  George Miller,et al.  When the cost curve bent--pre-recession moderation in health care spending. , 2012, The New England journal of medicine.

[4]  Ruth A. Judson,et al.  Improving the Measurement of Cross-Border Securities Holdings: The Treasury International Capital SLT , 2012 .

[5]  Sowmya R. Rao,et al.  Methodological issues in using multiple years of the Medicare current beneficiary survey. , 2012, Medicare & medicaid research review.

[6]  D. Alley,et al.  Mortgage delinquency and changes in access to health resources and depressive symptoms in a nationally representative cohort of Americans older than 50 years. , 2011, American journal of public health.

[7]  Jeanne M. Madden,et al.  Medicare Part D and Changes in Prescription Drug Use and Cost Burden: National Estimates for the Medicare Population, 2000 to 2007 , 2011, Medical care.

[8]  Jeanne M. Madden,et al.  Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors , 2011, Journal of cancer survivorship : research and practice.

[9]  Robert E. Hall,et al.  Why Does the Economy Fall to Pieces after a Financial Crisis , 2010 .

[10]  V. Reno,et al.  Economic Status of the Elderly in the United States , 2010 .

[11]  T. Brennan,et al.  Changes in Drug Use and Out‐of‐Pocket Costs Associated with Medicare Part D Implementation: A Systematic Review , 2010, Journal of the American Geriatrics Society.

[12]  J. Gurwitz,et al.  Out-of-Pocket Burden of Health Care Spending and the Adequacy of the Medicare Part D Low-Income Subsidy , 2010, Medical care.

[13]  Jonathan Cylus,et al.  Health spending projections through 2019: the recession's impact continues. , 2010, Health affairs.

[14]  Juliette Cubanski,et al.  Medicare Part D update--lessons learned and unfinished business. , 2009, The New England journal of medicine.

[15]  S. Soumerai,et al.  Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[16]  S. Soumerai,et al.  Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. , 2009, Journal of the American Medical Association (JAMA).

[17]  Fang Zhang,et al.  Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. , 2008, JAMA.

[18]  J. Gurwitz,et al.  Reliability of New Measures of Cost-Related Medication Nonadherence , 2008, Medical care.

[19]  William D. Marder,et al.  Multiple Chronic Conditions: Prevalence, Health Consequences, and Implications for Quality, Care Management, and Costs , 2007, Journal of General Internal Medicine.

[20]  Dana P Goldman,et al.  Prescription drug cost sharing: associations with medication and medical utilization and spending and health. , 2007, JAMA.

[21]  J. Gurwitz,et al.  Depression and cost-related medication nonadherence in Medicare beneficiaries. , 2007, Archives of general psychiatry.

[22]  J. Gurwitz,et al.  Patients At-Risk for Cost-Related Medication Nonadherence: A Review of the Literature , 2007, Journal of General Internal Medicine.

[23]  J. Gurwitz,et al.  Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. , 2006, Archives of internal medicine.

[24]  Karen B DeSalvo,et al.  Predicting mortality and healthcare utilization with a single question. , 2001, Health services research.

[25]  I. Wilson,et al.  Prescription drug coverage and seniors: findings from a 2003 national survey. , 2005, Health affairs.

[26]  David O Meltzer,et al.  Physician strategies to reduce patients' out-of-pocket prescription costs. , 2005, Archives of internal medicine.

[27]  K. Langa,et al.  The Health Effects of Restricting Prescription Medication Use Because of Cost , 2004, Medical care.

[28]  I. Wilson,et al.  Prescription drug coverage and seniors: how well are states closing the gap? , 2002, Health affairs.

[29]  S. Soumerai,et al.  Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia , 1994 .

[30]  S B Soumerai,et al.  Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. , 1991, The New England journal of medicine.